|
TIMM22 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.95150000287848E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.2545000017723E-08 |
| Normal-vs-Stage2 |
3.124600E-01 |
| Normal-vs-Stage3 |
5.198100E-02 |
| Normal-vs-Stage4 |
4.789600E-01 |
| Stage1-vs-Stage2 |
5.861600E-02 |
| Stage1-vs-Stage3 |
2.563400E-01 |
| Stage1-vs-Stage4 |
1.856410E-01 |
| Stage2-vs-Stage3 |
4.385600E-01 |
| Stage2-vs-Stage4 |
9.480600E-01 |
| Stage3-vs-Stage4 |
5.981400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.09549999469405E-08 |
| Normal-vs-AfricanAmerican |
1.439390E-03 |
| Normal-vs-Asian |
2.950400E-01 |
| Caucasian-vs-AfricanAmerican |
9.150100E-02 |
| Caucasian-vs-Asian |
9.061600E-01 |
| AfricanAmerican-vs-Asian |
6.668200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.98740000304454E-08 |
| Normal-vs-Female |
8.438600E-04 |
| Male-vs-Female |
3.518200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.133800E-02 |
| Normal-vs-Extreme_Weight |
1.6020199999911E-05 |
| Normal-vs-Obese |
5.035900E-04 |
| Normal-vs-Extreme_Obese |
9.498000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.282100E-02 |
| Normal_Weight-vs-Obese |
2.831000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.497400E-01 |
| Extreme_Weight-vs-Obese |
4.171400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.277800E-01 |
| Obese-vs-Extreme_Obese |
5.083600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.472500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.49079999970326E-07 |
| Normal-vs-Age(61-80Yrs) |
2.26540000003439E-06 |
| Normal-vs-Age(81-100Yrs) |
8.437000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.192400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.313400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.897500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.239400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.604100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.470100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66566760384512E-12 |
| Normal-VS-Type2 PRCC |
2.041800E-01 |
| Normal-VS-KIRP CIMP |
3.039600E-01 |
| Normal-VS-Unclassified PRCC |
2.162100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.17330000004578E-06 |
| Type1 PRCC-VS-KIRP CIMP |
8.183900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.086100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.927800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.275830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.088800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.642000E-02 |
| Normal-vs-N1 |
2.139800E-02 |
| Normal-vs-N2 |
3.154200E-01 |
| N0-vs-N1 |
6.113600E-01 |
| N0-vs-N2 |
1.452820E-01 |
| N1-vs-N2 |
3.760400E-02 |
|
|
